Volume 4, 2025

Towards electrochemical sensing of gemcitabine release from hybrid nanoparticles in pancreatic cancer cells

Abstract

Theranostic clinical translation has been hindered by the lack of analytical tools facilitating interrogation. Here we report the detection of a chemotherapeutic agent, gemcitabine, released via heat trigger, from a hybrid iron oxide–gold theranostic nanoparticle surface in vitro in pancreatic cancer cells by electrochemiluminescence directly addressing this analytical gap.

Graphical abstract: Towards electrochemical sensing of gemcitabine release from hybrid nanoparticles in pancreatic cancer cells

Article information

Article type
Communication
Submitted
25 Jun 2025
Accepted
30 Aug 2025
First published
03 Sep 2025
This article is Open Access
Creative Commons BY license

Sens. Diagn., 2025,4, 966-972

Towards electrochemical sensing of gemcitabine release from hybrid nanoparticles in pancreatic cancer cells

A. Oluwasanmi, K. Brown, C. Hoskins and L. Dennany, Sens. Diagn., 2025, 4, 966 DOI: 10.1039/D5SD00110B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements